Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Current Leases (2021 - 2022)

Goldenwell Biotech filings provide 2 years of Current Leases readings, the most recent being $25372.0 for Q4 2022.

  • On a quarterly basis, Current Leases fell 46.9% to $25372.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $25372.0, a 46.9% decrease, with the full-year FY2022 number at $25372.0, down 46.9% from a year prior.
  • Current Leases hit $25372.0 in Q4 2022 for Goldenwell Biotech, down from $29126.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $47779.0 in Q4 2021 to a low of $17069.0 in Q1 2021.